Supplementary
pUC18Not Ap r ; identical to pUC18 but with two NotI sites flanking pUC18 polylinker Herrero et al., (1990) p34S-Km3 Km r , Ap r ; Km3 antibiotic cassette Dennis and Zylstra (1998) pNJ5000 Tc r ; Mobilizing plasmid used in marker exchange Grinter (1983) Supplementary Table S4 . Oligonucleotides used in this study. SM39  GCTCATAACGACACAATGCTGGTCCGGGAACAACAAGAAGTGAAGGCGGGTCAAAAAATA 60  Db11  GCTCATAACGACACAATGCTGGTCCGGGAACAACAAGAAGTGAAGGCGGGTCAAAAAATA 60  WW4  GCTCATAACGACACAATGCTGGTCCGGGAACAACAAGAAGTGAAGGCGGGTCAAAAAATA 60  ATCC_27592  GCTCACAACGACACAATGCTGGTCCGGGAACAACAAGAAGTGAAGGCGGGTCAAAAAATA 60  568  GCTCACAACGACACAATGCTGGTCCGGGAACAACAAGAAGTGAAGGCGGGTCAAAAAATA 60  A153  GCTCACAACGACACAATGCTGGTCCGGGAACAACAAGAAGTGAAGGCGGGTCAAAAAATA 60  4Rx5  GCTCACAACGACACAATGCTGGTCCGGGAACAACAAGAAGTGAAGGCGGGTCAAAAAATA 60  4Rx13 GCTCACAACGACACAATGCTGGTCCGGGAACAACAAGAAGTGAAGGCGGGTCAAAAAATA 60 S13
Number Name Sequence (5´-3') Description Source
GCTCACAACGACACAATGCTGGTCCGGGAACAACAAGAAGTGAAGGCGGGTCAAAAAATA 60 AS13
GCTCACAACGACACAATGCTGGTCCGGGAACAACAAGAAGTGAAGGCGGGTCAAAAAATA 60 AS12
GCTCACAACGACACAATGCTGGTCCGGGAACAACAAGAAGTGAAGGCGGGTCAAAAAATA 60 AS9
GCTCACAACGACACAATGCTGGTCCGGGAACAACAAGAAGTGAAGGCGGGTCAAAAAATA 60 V4
GCTCACAACGACACAATGCTGGTCCGGGAACAACAAGAAGTGAAGGCGGGTCAAAAAATA 60 FGI94
GCTCATAACGACACAATGCTGGTCCGGGAACAACAAGAAGTGAAGGCGGGTCAAAAAATA 60 RB-25 GCCCATAACGACACAATGCTGGTCCGGGAACAACAAGAGGTGAAGGCGGGGCAAAAAATA 60 ** ** ******************************** *********** ********* SM39 GCCACCATGGGTAGCACCGGTACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 Db11
GCCACCATGGGTAGCACCGGTACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 WW4
GCCACCATGGGTAGCACCGGTACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 ATCC_27592
GCCACCATGGGTAGCACCGGAACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 568 GCCACCATGGGTAGCACCGGAACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 A153
GCCACCATGGGTAGCACCGGAACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 4Rx5 GCCACCATGGGTAGCACCGGAACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 4Rx13 GCCACCATGGGTAGCACCGGAACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 S13 GCCACCATGGGTAGCACCGGAACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 AS13 GCCACCATGGGTAGCACCGGAACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 AS12 GCCACCATGGGTAGCACCGGAACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 AS9 GCCACCATGGGTAGCACCGGAACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 V4 GCCACCATGGGTAGCACCGGAACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 FGI94 GCCACCATGGGTAGCACCGGAACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 RB-25 GCAACGATGGGAAGCACCGGAACCAGTTCAGTACGTTTGCATTTTGAAATTCGTTACAAG 120 ** ** ***** ******** *************************************** SM39 GGGAAATCCGTAAACCCGCTGCGTTATCTTCCGCAGCGATAGATTGGGCAGAATACGCTG 180  Db11  GGGAAATCCGTAAACCCGCTGCGTTATCTTCCGCAGCGATAGATTGGGCAGAATACGCTG 180  WW4  GGGAAATCCGTAAACCCGCTGCGTTATCTTCCGCAGCGATAGATTGGGCAGAATACGCTG 180  ATCC_27592  GGGAAATCCGTAAACCCGCTGCGTTATCTTCCGCAGCGATAGATTGGGCAGAATACGCTG 180  568  GGGAAATCCGTAAACCCGCTGCGTTATCTTCCGCAGCGATAGATTGGGCAGAATACGCTG 180  A153  GGGAAATCCGTAAACCCGCTGCGTTTTCTTCCGCAGCGATAGATTGGGCAGAATACGCTG 180  4Rx5  GGGAAATCCGTAAACCCGCTGCGTTTTCTTCCGCAGCGATAGATTGGGCAGAATACGCTG 180  4Rx13  GGGAAATCCGTAAACCCGCTGCGTTTTCTTCCGCAGCGATAGATTGGGCAGAATACGCTG 180  S13  GGGAAATCCGTAAACCCGCTGCGTTTTCTTCCGCAGCGATAGATTGGGCAGAATACGCTG 180  AS13  GGGAAATCCGTAAACCCGCTGCGTTTTCTTCCGCAGCGATAGATTGGGCAGAATACGCTG 180  AS12  GGGAAATCCGTAAACCCGCTGCGTTTTCTTCCGCAGCGATAGATTGGGCAGAATACGCTG 180  AS9  GGGAAATCCGTAAACCCGCTGCGTTTTCTTCCGCAGCGATAGATTGGGCAGAATACGCTG 180  V4  GGGAAATCCGTAAACCCGCTGCGTTTTCTTCCGCAGCGATAGATTGGGCAGAATACGCTG 180  FGI94 GGGAAATCCGTAAACCCGCTGCGTTATCTTCCGCAGCGATAGATTGGGCAGAATATGCTG 180 RB-25 GGGAAATCCGTAAACCCGCTGCGTTATCTTCCGCAGCGATAGATTGGACAGAGTGCGTTG 180 ************************* ********************* **** * * ** . The values showed the average expression at stationary phase of growth relative to the wild type expression. Samples for qPCR were taken after growing A153 and 4Rx5 strains in LB medium at 25 ºC for 6 h and 8 h, respectively (see Fig. S10 ). Data are the mean and standard deviation of three biological replicates.
SUPPLEMENTARY EXPERIMENTAL PROCEDURES

Construction of strains and plasmids
Chromosomal mutants of Serratia plymuthica strains were constructed by homologous recombination using derivative plasmids of the suicide vector pKNG101. These plasmids, which are listed in Table S3 , were confirmed by DNA sequencing and they carried mutant alleles or in-frame deletions for the replacement of wild type genes in the chromosome.
Primers used in this study are listed in Table S4 . In all cases, plasmids for mutagenesis were transferred to S. plymuthica strains by triparental conjugation using E. coli CC118λpir and E. coli HH26 (pNJ500) as helper. The plasmids for the construction of the in-frame deletions mutants were generated by amplifying the up-and downstream flanking regions of the gene or domain to be deleted. The resulting PCR products were digested with the enzymes specified in Table S3 and ligated in a three-way ligation into pUC18Not, previously cloned into the marker exchange vector pKNG101. The in-frame deletion mutant strains OOA, OOB, OOE, OOK, OOM, OcO, OOP, OOQ, OOT, OOU, OOV, OOV-AT1, OOV-AT2, OocVW and 4SplI were generated using plasmids pMAMV122, pMAMV133, pMAMV68, pMAMV65, pMAMV66, pMAMV123, pMAMV134, pMAMV124, pMAMV71, pMAMV67, pMAMV89, pMAMV86, pMAMV87, pMAMV180 and pMAMV181, respectively. Mutant AT1W was constructed using pMAMV86, and OocW as recipient strain. Alternatively, the 5´ and 3´ flanking regions of oocE and oocU were directly ligated in a three-way ligation into pKNG101. A153 LacZ was generated by deleting a 1.4 kb region of the lacZ gene using plasmid pMAMV112. A153 mutant strains defective in oocW, hfq and rpoS were constructed through the insertion of a kanamycin resistance cassette using plasmids pMAMV88, pMAMV160 and pMAMV113, respectively. The hfq gene and its genomic context in A153 and 4Rx5 are 100% identical and both strains AHfq and 4Hfq
were generated using pMAMV160. For the construction of the strains OocJ-ACP, OocS-TE and OocS-C, point mutations in the ACP L , TE and NRPS-C domains were generated by overlapping PCR. The final PCR product was cloned into pUC18Not previously to be cloned into the NotI site of pKNG101 and the plasmids pMAMV99, pMAMV100 and pMAMV101 were used for the construction of the strains OocJ-ACP, OocS-TE and OocS-C, respectively. All relevant mutations and were confirmed by PCR and sequencing.
For the construction of the complementing plasmids, the genes were amplified using primers described in Table S4 and cloned into pTA100 or pTRB30. To generate pAT1, pAT2 and pAT3, the catalytic serine present in the acyltransferase domains OocV-AT1,
OocV-AT2 and OocW-AT3 was replaced by alanine by overlapping PCR. All the inserts were confirmed by PCR and sequencing. For the construction of the transcriptional fusions to ´lacZ, the promoter regions of oocG and oocJ were amplified using primers described in Table S4 and subsequently cloned into pMP220. Complementing plasmids were transformed into Serratia and Dickeya strains by electroporation.
